Cardiac Sarcoidosis Response To Steroids Trial
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Registration Number
- NCT01210677
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
- First Posted Date
- 2010-08-18
- Last Posted Date
- 2011-11-11
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT01184300
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines
- Conditions
- Interventions
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2010-06-28
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 1608
- Registration Number
- NCT01151800
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial Imaging(Rb-ARMI)
- Conditions
- Interventions
- First Posted Date
- 2010-05-21
- Last Posted Date
- 2019-11-21
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 10000
- Registration Number
- NCT01128023
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease
- Conditions
- Interventions
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 194
- Registration Number
- NCT00962988
- Locations
- 🇨🇦
Hamilton Health Sciences -Stroke Prevention Clinic, Hamilton, Ontario, Canada
🇨🇦The Ottawa Hospital - Stroke Prevention Clinic, Ottawa, Ontario, Canada
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
- Conditions
- Interventions
- First Posted Date
- 2009-08-17
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT00959972
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Platelet Function Monitoring in Patients Treated With Clopidogrel at the Time of Primary Percutaneous Coronary Angioplasty
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00827346
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2008-12-01
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 984
- Registration Number
- NCT00800137
- Locations
- 🇨🇦
Sherbrooke University Hospital Centre CHUS, Sherbrooke, Quebec, Canada
🇨🇦Royal Jubilee Hospital, Victoria, British Columbia, Canada
🇨🇦Hamilton Health Science Center, Hamilton, Ontario, Canada
Cardiac FDG PET Viability Registry
- Conditions
- First Posted Date
- 2008-10-06
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 2000
- Registration Number
- NCT00766987
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇨🇦University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦University Health Network, Toronto, Ontario, Canada
CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea.
- Conditions
- Interventions
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 67
- Registration Number
- NCT00756366
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada